Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

Jerusalem Pharmaceuticals Company achieves a net income of JD0.88 million in H1 2013

2013-08-15

According to company data for the first six months of the year, net profit after taxes reached 879,087 USD, compared with a net loss of (853,058) USD from the first six months of 2012. Total assets of the company reached 52,614,881 USD as of June 30th, 2013, compared to total assets of 48,875,519 USD as of December 31st, 2012, a net increase of 7.7%. Total liabilities of the company reached 17,302,521 USD as of June 30th, 2013, compared to total liabilities of 15,164,804 USD as of December 31st, 2012, a net increase of 14.1%. Net ownership equity of the company reached 35,312,360 USD (including 837,484 USD in Non-controlling interest) as of June 30th, 2013, compared with a net ownership equity of 33,710,715 USD (including 951,501 USD in Non-controlling interest) as of December 31st, 2012, a net increase of 4.8% in the last six months. Furthermore, paid-in capital increased from 8,530,000 USD on December 31st, 2012 to 17,060,000 USD by June 30th, 2013, an increase of 100.0%.

 


 

2021-10-26
RSR posts net income of JD0.31 million in 9M 2021

2021-10-26
APC records net income of JD0.82 million in 9M 2021

2021-10-24
ARAB posts net income of JD0.02 million in 9M 2021

2021-10-21
Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

2021-10-17
PHARMACARE recommends distributing 10% cash dividends for the year 2020

2021-10-14
A transaction on the stocks of TRSUT raises the trading value in the PEX

2021-10-07
Al-Quds Index rebounds upwards in the first week of October

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013